Conquer Cancer Foundation Honors Oncology Professionals for High-quality Research in Breast Cancer


Get Permission

More than 15 leading young oncology professionals were honored this year by the Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO) with 2012 Breast Cancer Symposium Merit Awards for their work in breast cancer research. These trainees submitted high-quality abstracts selected for presentation at the 2012 Breast Cancer Symposium that took place in San Francisco on September 13-15, where they were recognized for their research in the areas of breast cancer disease management, survivorship care, health-care disparities and more.

“This year’s Merit Award recipients are helping to contribute to the growing body of clinical evidence in breast cancer that helps patients live longer and have better outcomes,” said Gary Levine, MD, Chair of the Breast Cancer Symposium Steering Committee. “We are honored to recognize the scientific advances of this year’s recipients as well as their dedication to improving care for patients living with breast cancer.”

Promoting Clinical Research by Young Investigators

The 2012 recipients and their abstract titles are featured on the Breast Cancer Symposium website at http://breastcasymposium.org/Abstracts/MeritAwards.aspx. The Conquer Cancer Foundation of ASCO Merit Awards are designed to promote clinical cancer research by young oncology investigators and provide them with the opportunity to present their research at the Breast Cancer Symposium, a multidisciplinary meeting for breast cancer clinicians and other oncology team members who treat and care for patients with breast cancer. This year’s Symposium focused on taking the latest scientific results in the field and bringing them into the clinic for practical application.

The 2012 Breast Cancer Symposium Merit Awards are supported by: Amgen; Astellas; AVEO Pharmaceuticals, Inc; Bristol-Myers Squibb; Celgene Corporation; Lilly USA, LLC; Millennium: The Takeda Oncology Company; Novartis Oncology; and Onyx Pharmaceuticals.

For more information about the Conquer Cancer Foundation’s Grants and Awards Program visit http://www.conquercancerfoundation.org. ■

© 2012. American Society of Clinical Oncology. All Rights Reserved.



Advertisement

Advertisement



Advertisement